tirzepatide compounding pharmacy lawsuit 🚨 URGENT: Being Pulled from the Market! 🚨 We've just received critical news—Tirzepatide will no longer be available after March 17th! Our has lost their lawsuit, meaning supplies will COMPOUNDED TIRZEPATIDE
Description
The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff
your dose might be too low, or diet changes are needed
Higher Dose Tier - $299/month
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plans prescription drug spending, so the state is no longer covering them for weight loss alone
How MNS Can Help Policy changes like this can create added administrative work and delays
Empower yourself with insights to navigate your emotional health effectively.
